Sun Pharmaceutical Industries reports 28% rise in Q2 consolidated net profit

28 Oct 2024 Evaluate

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2024 (Q2FY25).

The company has reported 2.85% fall in net profit at Rs 863.29 crore for Q2FY25 as compared to Rs 888.63 crore for the same quarter in the previous year. However, total income of the company increased by 0.22% at Rs 5214.01 crore for Q2FY25 as compared to Rs 5202.75 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 27.98% rise in its net profit at Rs 3040.16 crore for the quarter ended September 30, 2024 as compared to Rs 2375.51 crore for the same quarter in the previous year. Total income of the company increased by 9.29% at Rs 13645.39 crore for Q2FY25 as compared to Rs 12486.02 crore for the corresponding quarter previous year.

Sun Pharma Inds. Share Price

1798.60 -9.60 (-0.53%)
03-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.60
Dr. Reddys Lab 1225.10
Cipla 1534.40
Lupin 2081.40
Zydus Lifesciences 982.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.